This inventor holds 1 USPTO granted patent. Top assignee: Amalive Limited. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Jan Stange: Inventor in Liver Disease Treatment
Introduction
Jan Stange is an inventor based in San Diego, California. His patent work addresses hyperammonemia, a condition associated with chronic liver disease.
Latest Patents
Stange is associated with 1 patent: “Dosages and Uses of Ornithine Phenylacetate for Treating Hyperammonemia.” The disclosure describes doses and methods of administering ornithine phenylacetate to treat or ameliorate hyperammonemia in patients with chronic liver disease, such as cirrhosis. Some embodiments also address patients with hepatic encephalopathy as a complication of liver disease.
Career Highlights
Stange is associated with Amalive Limited. His patent focuses on potential treatment approaches for hyperammonemia in people with chronic liver disease.
Collaborations
His listed coworkers include Xiaofeng Wang Rears and Jack Tseng.
Conclusion
Jan Stange’s patent work centers on ornithine phenylacetate dosing and administration for hyperammonemia, reflecting a focus on treatment needs related to chronic liver disease.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile